Cargando…

Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula

Sepsis has a high mortality rate, and treating sepsis remains a significant challenge worldwide. In former studies, our group found that traditional Chinese medicine, Shen FuHuang formula (SFH), is a promising medicine in treating coronavirus disease 2019 (COVID-19) patients with the septic syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Shasha, Zhao, Chunxia, Guo, Yuhong, Zhao, Jingxia, Xu, Xiaolong, Hu, Yahui, Lian, Bo, Ye, Haoran, Wang, Ning, Luo, Lianxiang, Liu, Qingquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030955/
https://www.ncbi.nlm.nih.gov/pubmed/36970673
http://dx.doi.org/10.3389/fmicb.2023.1111962
_version_ 1784910491808694272
author He, Shasha
Zhao, Chunxia
Guo, Yuhong
Zhao, Jingxia
Xu, Xiaolong
Hu, Yahui
Lian, Bo
Ye, Haoran
Wang, Ning
Luo, Lianxiang
Liu, Qingquan
author_facet He, Shasha
Zhao, Chunxia
Guo, Yuhong
Zhao, Jingxia
Xu, Xiaolong
Hu, Yahui
Lian, Bo
Ye, Haoran
Wang, Ning
Luo, Lianxiang
Liu, Qingquan
author_sort He, Shasha
collection PubMed
description Sepsis has a high mortality rate, and treating sepsis remains a significant challenge worldwide. In former studies, our group found that traditional Chinese medicine, Shen FuHuang formula (SFH), is a promising medicine in treating coronavirus disease 2019 (COVID-19) patients with the septic syndrome. However, the underlying mechanisms remain elusive. In the present study, we first investigated the therapeutic effects of SFH on septic mice. To investigate the mechanisms of SFH-treated sepsis, we identified the gut microbiome profile and exploited untargeted metabolomics analyses. The results demonstrated that SFH significantly enhanced the mice’s 7-day survival rate and hindered the release of inflammatory mediators, i.e., TNF-α, IL-6, and IL-1β. 16S rDNA sequencing further deciphered that SFH decreased the proportion of Campylobacterota and Proteobacteria at the phylum level. LEfSe analysis revealed that the treatment of SFH enriched Blautia while decreased Escherichia_Shigella. Furthermore, serum untargeted metabolomics analysis indicated that SFH could regulate the glucagon signaling pathway, PPAR signaling pathway, galactose metabolism, and pyrimidine metabolism. Finally, we found the relative abundance of Bacteroides, Lachnospiraceae_NK4A136_group, Escherichia_Shigella, Blautia, Ruminococcus, and Prevotella were closely related to the enrichment of the metabolic signaling pathways, including L-tryptophan, uracil, glucuronic acid, protocatechuic acid, and gamma-Glutamylcysteine. In conclusion, our study demonstrated that SFH alleviated sepsis by suppressing the inflammatory response and hence reduced mortality. The mechanism of SFH for treating sepsis may be ascribed to the enrichment of beneficial gut flora and modulation in glucagon signaling pathway, PPAR signaling pathway, galactose metabolism, and pyrimidine metabolism. To sum up, these findings provide a new scientific perspective for the clinical application of SFH in treating sepsis.
format Online
Article
Text
id pubmed-10030955
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100309552023-03-23 Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula He, Shasha Zhao, Chunxia Guo, Yuhong Zhao, Jingxia Xu, Xiaolong Hu, Yahui Lian, Bo Ye, Haoran Wang, Ning Luo, Lianxiang Liu, Qingquan Front Microbiol Microbiology Sepsis has a high mortality rate, and treating sepsis remains a significant challenge worldwide. In former studies, our group found that traditional Chinese medicine, Shen FuHuang formula (SFH), is a promising medicine in treating coronavirus disease 2019 (COVID-19) patients with the septic syndrome. However, the underlying mechanisms remain elusive. In the present study, we first investigated the therapeutic effects of SFH on septic mice. To investigate the mechanisms of SFH-treated sepsis, we identified the gut microbiome profile and exploited untargeted metabolomics analyses. The results demonstrated that SFH significantly enhanced the mice’s 7-day survival rate and hindered the release of inflammatory mediators, i.e., TNF-α, IL-6, and IL-1β. 16S rDNA sequencing further deciphered that SFH decreased the proportion of Campylobacterota and Proteobacteria at the phylum level. LEfSe analysis revealed that the treatment of SFH enriched Blautia while decreased Escherichia_Shigella. Furthermore, serum untargeted metabolomics analysis indicated that SFH could regulate the glucagon signaling pathway, PPAR signaling pathway, galactose metabolism, and pyrimidine metabolism. Finally, we found the relative abundance of Bacteroides, Lachnospiraceae_NK4A136_group, Escherichia_Shigella, Blautia, Ruminococcus, and Prevotella were closely related to the enrichment of the metabolic signaling pathways, including L-tryptophan, uracil, glucuronic acid, protocatechuic acid, and gamma-Glutamylcysteine. In conclusion, our study demonstrated that SFH alleviated sepsis by suppressing the inflammatory response and hence reduced mortality. The mechanism of SFH for treating sepsis may be ascribed to the enrichment of beneficial gut flora and modulation in glucagon signaling pathway, PPAR signaling pathway, galactose metabolism, and pyrimidine metabolism. To sum up, these findings provide a new scientific perspective for the clinical application of SFH in treating sepsis. Frontiers Media S.A. 2023-03-08 /pmc/articles/PMC10030955/ /pubmed/36970673 http://dx.doi.org/10.3389/fmicb.2023.1111962 Text en Copyright © 2023 He, Zhao, Guo, Zhao, Xu, Hu, Lian, Ye, Wang, Luo and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
He, Shasha
Zhao, Chunxia
Guo, Yuhong
Zhao, Jingxia
Xu, Xiaolong
Hu, Yahui
Lian, Bo
Ye, Haoran
Wang, Ning
Luo, Lianxiang
Liu, Qingquan
Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula
title Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula
title_full Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula
title_fullStr Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula
title_full_unstemmed Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula
title_short Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula
title_sort alterations in the gut microbiome and metabolome profiles of septic mice treated with shen fuhuang formula
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030955/
https://www.ncbi.nlm.nih.gov/pubmed/36970673
http://dx.doi.org/10.3389/fmicb.2023.1111962
work_keys_str_mv AT heshasha alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula
AT zhaochunxia alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula
AT guoyuhong alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula
AT zhaojingxia alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula
AT xuxiaolong alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula
AT huyahui alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula
AT lianbo alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula
AT yehaoran alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula
AT wangning alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula
AT luolianxiang alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula
AT liuqingquan alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula